Officinae Bio
Davide De Lucrezia is the Co-founder and Chief Executive Officer of Officinae Bio. DAVIDE is also the Chairman and Co-founder & CEO of Explora Biotech Srl. With a background in Biochemistry and Molecular Biology, DAVIDE has held positions such as Adjunct Professor in Bio-nanomaterials and Senior Researcher at various institutions including Università Ca' Foscari di Venezia and Irccs San Raffaele Pisana. Davide has also worked as a Research technician at Polyphor AG and as a Lab technician at ETH Zurich.
This person is not in any teams
Officinae Bio
At Officinae Bio we're developing a platform to support the future of biologically designed therapeutics. By developing breakthroughs in AI-enabled methodologies for nucleic manufacture we’re supporting pioneering research in Gene-modified Cell therapy, Gene therapy and RNA therapeutic research. DNA platform An automated platform for streamlined development of plasmids and libraries for viral vector and mRNA. RNA platform Our industry leading mRNA development and manufacturing solutions support rapid turnaround, advanced transcription capabilities and precision control over regulatory sequences design.